Comparison
11p Partial Monosomy Syndrome C0206115 vs 17 20 Lyase Deficiency Isolated C3277849
Clinical comparison between 11p Partial Monosomy Syndrome and 17 20 Lyase Deficiency Isolated for differential diagnosis and treatment planning.
11p Partial Monosomy Syndrome C0206115
A rare genetic disorder involving deletion of material from chromosome 11. It may result in developmental delays, distinctive facial features, and various medical concerns. Treatment is supportive and individualized based on symptoms.
17 20 Lyase Deficiency Isolated C3277849
A rare enzymatic disorder affecting sex hormone production. Impairs development of sexual characteristics in both males and females. Treatment involves hormone supplementation.
6 comparison axes
Onset
11p Partial Monosomy Syndrome C0206115
0-0
17 20 Lyase Deficiency Isolated C3277849
0-18
Onset patterns differ
Severity
11p Partial Monosomy Syndrome C0206115
severe
17 20 Lyase Deficiency Isolated C3277849
severe
Different severity levels
Chronic
11p Partial Monosomy Syndrome C0206115
Chronic
17 20 Lyase Deficiency Isolated C3277849
Chronic
Differing course
Communicable
11p Partial Monosomy Syndrome C0206115
No
17 20 Lyase Deficiency Isolated C3277849
No
Different transmission
Body System
11p Partial Monosomy Syndrome C0206115
congenital
17 20 Lyase Deficiency Isolated C3277849
endocrine
Same/different system
Category
11p Partial Monosomy Syndrome C0206115
genetic
17 20 Lyase Deficiency Isolated C3277849
endocrine
Different category
Bottom line
11p-partial-monosomy-syndrome-C0206115 and 17-20-lyase-deficiency-isolated-C3277849 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 11p Partial Monosomy Syndrome C0206115 | 17 20 Lyase Deficiency Isolated C3277849 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Developmental delay and congenital features may be prominent. | Sex-hormone-related development is mainly affected; global delay is not established. | High |
| Physical findings | Distinctive facial or multisystem congenital findings may occur. | Atypical genital or pubertal development may occur; exact features vary. | Moderate |
| Endocrine presentation | Hormone abnormalities are not the defining feature in the supplied description. | Impaired sex-hormone production is central. | High |
When to favor each condition
Choose 11p Partial Monosomy Syndrome C0206115 when
Congenital multisystem presentation
Chromosomal deletion better fits developmental delay with congenital findings.
Moderate
Suspected chromosomal imbalance
Genetic testing is more relevant than isolated steroid-enzyme testing.
High
No primary sex-steroid defect
Absence of an isolated endocrine pattern favors considering the chromosomal condition.
Low
Choose 17 20 Lyase Deficiency Isolated C3277849 when
Disordered sexual development
Isolated 17,20-lyase deficiency specifically impairs sex-hormone production.
Moderate
Pubertal or genital findings
Endocrine evaluation is prioritized when sex-steroid deficiency is suspected.
Moderate
Normal chromosomal study
A normal karyotype or microarray does not exclude an enzyme defect.
Moderate
How key tests differ
| Test | 11p Partial Monosomy Syndrome C0206115 | 17 20 Lyase Deficiency Isolated C3277849 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May show deletion involving 11p; exact extent varies. | Not expected to identify the enzyme defect. | A chromosomal result supports, but does not by itself define, the syndrome. |
| Steroid hormone profile | No specific pattern is established from the supplied data. | May suggest impaired sex-steroid synthesis; cutoffs are not stated here. | Abnormal results require endocrine confirmation and are not a diagnosis alone. |
| CYP17A1 or related genetic testing | Not the primary test suggested by a chromosomal deletion. | May identify a relevant variant when clinically indicated. | Variant interpretation belongs to a genetics or endocrine specialist. |
Prognosis comparison
11p Partial Monosomy Syndrome C0206115
- Outcome
- Often chronic and potentially severe, but individual outcome is not established here.
- Factors
- Deletion extent, associated anomalies, and developmental needs may influence course.
17 20 Lyase Deficiency Isolated C3277849
- Outcome
- Chronic endocrine effects may be manageable with appropriate hormone care.
- Factors
- Diagnosis timing, hormone deficiency severity, and treatment response matter.
Time frame: From infancy or childhood into long-term follow-up; exact timelines are not established.
Accurate diagnosis, associated conditions, access to specialists, and individualized support.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Delays and associated medical needs may be substantial. Global developmental complications are not established. Support needs should be individualized. |
| Reproductive or pubertal effects | Not specifically established by the supplied description. Sexual development may be impaired in either sex. Hormone care should be specialist-directed; doses are not provided. |
| Associated congenital concerns | Various organ or structural concerns may occur. Primarily an endocrine disorder rather than a multisystem deletion syndrome. Screening should follow clinical findings, not assumptions. |
Patient education highlights
- HighDifferent causes
One condition involves missing chromosomal material; the other is an enzyme problem affecting sex hormones.
- HighSpecialist care
Genetics and endocrinology input may be needed. Do not rely on a single abnormal result.
- MediumIndividualized support
Therapies, hormone treatment, and monitoring depend on confirmed findings and symptoms.